Explore
Trendline
SOPHiA GENETICS Reports Strong Q1 2026 Growth Driven by AI-Powered Precision Medicine
SOPHiA GENETICS Reports Strong Q1 2026 Growth Driven by AI-Powered Precision Medicine
Read More
Trendline
Soleno Therapeutics Faces Securities Fraud Allegations in Class Action Lawsuit
Soleno Therapeutics Faces Securities Fraud Allegations in Class Action Lawsuit
Read More
Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Read More
Trendline
Schrödinger to Engage Investors at May 2026 Conferences
Schrödinger to Engage Investors at May 2026 Conferences
Read More
Trendline
Stevanato Group to Participate in Three Major Investor Conferences
Stevanato Group to Participate in Three Major Investor Conferences
Read More
Trendline
Nektar Therapeutics Faces Securities Fraud Lawsuit, Investors Encouraged to Lead
Nektar Therapeutics Faces Securities Fraud Lawsuit, Investors Encouraged to Lead
Read More
Trendline
Jim Cramer Defends AMD Amid Downgrade, Predicts Stock Upsurge
Jim Cramer Defends AMD Amid Downgrade, Predicts Stock Upsurge
Read More
Trendline
Rosen Law Firm Urges Atara Biotherapeutics Investors to Act Before Class Action Deadline
Rosen Law Firm Urges Atara Biotherapeutics Investors to Act Before Class Action Deadline
Read More
Trendline
Kessler Topaz Meltzer Check, LLP Alerts ImmunityBio Investors of Securities Fraud Class Action
Kessler Topaz Meltzer Check, LLP Alerts ImmunityBio Investors of Securities Fraud Class Action
Read More
Trendline
Boston Scientific Faces Securities Fraud Lawsuit Over Misleading Statements
Boston Scientific Faces Securities Fraud Lawsuit Over Misleading Statements
Read More
Trendline
Rosen Law Firm Urges Atara Biotherapeutics Investors to Join Securities Class Action Before Deadline
Rosen Law Firm Urges Atara Biotherapeutics Investors to Join Securities Class Action Before Deadline
Read More
Trendline
ImmunityBio Faces Securities Fraud Lawsuit Over Misleading Cancer Drug Claims
ImmunityBio Faces Securities Fraud Lawsuit Over Misleading Cancer Drug Claims
Read More
